C&EN

30 Years Of Generics

In September 1984, the Drug Price Competition & Patent Term Restoration Act, commonly known as the Hatch-Waxman Act for its congressional sponsors’ names, was signed into U.S. law. By creating a new ...
Health Affairs

Medicare Part D Plans Rarely Cover Brand-Name Drugs When Generics Are Available

Recent press reports and other evidence suggest that Medicare Part D plans may be encouraging the use of brand-name drugs instead of generics. However, the scope of such practices is unclear. We ...
The American Journal of Managed Care

Competition From Skinny-Label Generics Saved Medicare Nearly $15B Over 5 Years

A new court ruling has the future use of skinny labels in question, but skinny-label generics have saved Medicare a lot of money over 5 years. Skinny labels, which carve out patent-protected ...
Health Affairs

Authorized Generics In The US: Prevalence, Characteristics, And Timing, 2010–19

Annabelle C. Fowler, Charles River Associates, Boston, Massachusetts. Ruben Jacobo-Rubio, Food and Drug Administration, Silver Spring, Maryland. Jing Xu ([email protected]), Food and Drug ...
NPR

FDA Fees On Industry Haven't Fixed Delays In Generic Drug Approvals

Consumers and lawmakers pushing for cheaper alternatives to the EpiPen, an antidote for life-threatening allergic reactions, and other high-priced drugs are seeking answers about a stubborn backlog of ...